Identification of proteins interacting with ALK in neuroblastoma.
|
Dana-Farber Cancer Institute / Rani George |
Young Investigator Grants |
2009 |
Massachusetts |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |
BH3 profiling to define therapy resistance classes in neuroblastoma.
|
Children’s Hospital of Philadelphia / Michael Hogarty |
Innovation Grants |
2009 |
Pennsylvania |
Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |
Increasing the Availability and Quality of Early Phase Clinical Trials Through the Addition of a Specialized Pediatric Advanced Nurse Practitioner
|
Children’s Memorial Hospital / Stewart Goldman |
Phase I/II Infrastructure Grants |
2008 |
Illinois |
Advanced Therapeutics for Pediatric Cancer
|
Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD |
Phase I/II Infrastructure Grants |
2008 |
Washington |
PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma
|
Emory University / Donald Durden |
Innovation Grants |
2008 |
Georgia |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Therapeutics In Ovo
|
Oregon Health & Science University / Charles Keller |
Innovation Grants |
2008 |
Oregon |